guluronic acid has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghazadeh, Z; Hoseini, M; Mirshafiey, A; Mobini, M; Moghadam, NB; Noorbakhsh, SM; Oraei, M; Razavi, A; Saadat, P | 1 |
| Abdollahi, M; Aghazadeh, Z; Fattahi, MJ; Khadem Azarian, S; Mirshafiey, A; Nazeri, S; Sedaghat, R; Tofighi Zavareh, F | 1 |
2 other study(ies) available for guluronic acid and Multiple Sclerosis
| Article | Year |
|---|---|
Effects of guluronic acid (G2013) on gene expression of TLR2, TLR4, MyD88, TNF-α and CD52 in multiple sclerosis under in vitro conditions.
Topics: Adult; CD52 Antigen; Female; Gene Expression Regulation; Hexuronic Acids; Humans; Male; Middle Aged; Multiple Sclerosis; Myeloid Differentiation Factor 88; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Glucuronic Acid; Hexuronic Acids; Immunologic Factors; Male; Mice; Mice, Inbred BALB C; Multiple Sclerosis; Rats; Uronic Acids | 2017 |